Name: MILESTONE PHARMACEUTICALS IN (MIST) Stock
Brand: MILESTONE PHARMACEUTICALS IN
Rating: 5.5 (3 reviews)

MIST Latest News, Press Relases and Analysis

All

Press Releases

10 days ago - By: Chartmill

Milestone Pharmaceuticals (NASDAQ:MIST) Posts Narrower-Than-Expected Q3 Loss as Key FDA Decision Looms

10 days ago - By: Milestone Pharmaceuticals Inc.

Milestone Pharmaceuticals Reports Third Quarter 2025 Financial Results and Provides Regulatory and Corporate Update

19 days ago - By: Milestone Pharmaceuticals Inc.

Milestone Pharmaceuticals to Present New Analysis from Investigational Etripamil Nasal Spray Clinical Trials for PSVT at the American Heart Association Scientific Sessions 2025

a month ago - By: Milestone Pharmaceuticals Inc.

Milestone® Pharmaceuticals to Present Data on Etripamil at the American Heart Association Scientific Sessions 2025

3 months ago - By: Milestone Pharmaceuticals Inc.

Milestone® Pharmaceuticals to Present at Upcoming Conferences

3 months ago - By: Milestone Pharmaceuticals Inc.

Milestone Pharmaceuticals Reports Second Quarter 2025 Financial Results and Provides Regulatory and Corporate Update

4 months ago - By: Benzinga - Mentions: WDFC AGM SGN TMDX ...

Crude Oil Rises Sharply; Milestone Pharmaceuticals Shares Plunge

4 months ago - By: Benzinga - Mentions: CALC KPTI CAPR ATHE ...

12 Health Care Stocks Moving In Friday's Intraday Session

4 months ago - By: Milestone Pharmaceuticals Inc.

Milestone Pharmaceuticals Announces Pricing of $52.5 Million Public Offering of Common Shares, Pre-Funded Warrants, Series A Common Warrants and Series B Common Warrants

4 months ago - By: Milestone Pharmaceuticals Inc.

Milestone Pharmaceuticals Announces Proposed Public Offering

4 months ago - By: Milestone Pharmaceuticals Inc.

Milestone Pharmaceuticals Announces FDA Acceptance of the Company’s Response to the CRL for CARDAMYST™ (etripamil) Nasal Spray

6 months ago - By: Zacks Investment Research

Milestone Pharmaceuticals (MIST) Upgraded to Buy: Here's Why

6 months ago - By: Milestone Pharmaceuticals Inc.

Milestone Pharmaceuticals Reports First Quarter 2025 Financial Results and Provides Regulatory and Corporate Update

8 months ago - By: Yahoo Finance - Mentions: TSLA BLK

Milestone Pharmaceuticals downgraded to Hold from Buy at TD Cowen

8 months ago - By: Yahoo Finance - Mentions: ICON LTRY APTO META ...

Icon Energy to effect 1-for-40 reverse stock split

8 months ago - By: Yahoo Finance - Mentions: APTO WGO BRZE IDXX ...

Milestone CRL affirms integrity of clinical data, says H.C. Wainwright

8 months ago - By: Yahoo Finance - Mentions: RJF WFC BRZE LVLU ...

Braze price target raised to $55 from $50 at Citi

8 months ago - By: Stocktwits - Mentions: GWX NVDA

Milestone Pharmaceuticals Stock Plunges 60% After FDA Declines To Approve Its Cardamyst Nasal Spray – But Retail’s Positive

8 months ago - By: Milestone Pharmaceuticals Inc.

FDA Issues Complete Response Letter for Etripamil for PSVT

8 months ago - By: Milestone Pharmaceuticals Inc.

Milestone Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Regulatory and Corporate Update

9 months ago - By: Milestone Pharmaceuticals Inc.

Milestone Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

9 months ago - By: Milestone Pharmaceuticals Inc.

Milestone Pharmaceuticals to Host Commercial Launch Plan Investor Event in New York on February 25, 2025

10 months ago - By: Milestone Pharmaceuticals Inc.

Milestone Pharmaceuticals Provides 2025 Corporate Outlook and Will Host Investor Event on February 25 in NYC

11 months ago - By: Milestone Pharmaceuticals Inc.

MILESTONE PHARMACEUTICALS IN (MIST) Stock News

MIST Latest News, Press Relases and Analysis